Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time
| Status: | Recruiting |
|---|---|
| Conditions: | Arthritis, Rheumatoid Arthritis, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases, Rheumatology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 8/8/2018 |
| Start Date: | May 10, 2018 |
| End Date: | December 1, 2024 |
| Contact: | Aubri Atkin |
| Email: | AtkinA@NJHealth.org |
| Phone: | 303-270-1220 |
Change in Serum and Sputum Biomarkers Over Time in the Development of Rheumatoid Arthritis-associated Lung Disease
The purpose of this study is to investigate the link between the lungs and rheumatoid
arthritis (RA). Additionally, to understand why RA patients get lung disease, how to treat,
and prevent the disease.
arthritis (RA). Additionally, to understand why RA patients get lung disease, how to treat,
and prevent the disease.
This study is to learn more about the risk factors for the development of lung disease among
patients with rheumatoid arthritis (RA), an auto-immune disease. Additionally, those at
heightened risk of developing RA such as in the pre-RA period. This is a prospective and
retrospective study, which 420 patients will be enrolled into the study. In-person
participation will be up to 4 years, completing different standard of care assessments
yearly. Additionally, quality of life questionnaires will be completed every 6 months at 4
time points. Lastly, an extended follow-up will be performed yearly for an additional 6
years, an overall 10 year participation.
patients with rheumatoid arthritis (RA), an auto-immune disease. Additionally, those at
heightened risk of developing RA such as in the pre-RA period. This is a prospective and
retrospective study, which 420 patients will be enrolled into the study. In-person
participation will be up to 4 years, completing different standard of care assessments
yearly. Additionally, quality of life questionnaires will be completed every 6 months at 4
time points. Lastly, an extended follow-up will be performed yearly for an additional 6
years, an overall 10 year participation.
Inclusion Criteria:
1. Age 18 - 80 years
Exclusion Criteria:
1. Subjects who do not speak English
2. Subjects without the capacity to sign the informed consent form (ICF)
3. Pregnant women
We found this trial at
1
site
National Jewish Health National Jewish Health is known worldwide for treatment of patients with respiratory,...
Click here to add this to my saved trials
